Roche quarterly sales rise 3 percent after franc shock, beat views

April 22, 2015 5:13 AM

2 0

ZURICH, April 22 (Reuters) - Roche, the world's biggest maker of cancer drugs, reported a 3 percent rise in sales in the first quarter on Wednesday, with growth held back by a strong Swiss franc.

The Basel-based firm said sales in the first three months rose to 11.833 billion Swiss francs ($12.40 billion) from 11.496 billion year-ago. This beat analyst views, which averaged 11.492 billion in a Reuters poll.

Also read: BAT offers to buy U.S. tobacco firm Reynolds in $47 billion deal

Read more

To category page